But in the words of my coworker Paul Simmons, "I know what HIV is and I'm not afraid if it." If the recent "wait to treat" federal guidelines are to be believed, HIV'ers shouldn't be afraid either. Since their inception in 1986, the guidelines have been established in the hope that nonspecialists would have a slight inkling of how to treat a patient with HIV.
The newest guidelines tell us what we've known for a while -- the side effects associated with long-lasting HIV drug therapy outweigh the benefits. In light of this, the feds have recommended that otherwise healthy patients not begin HIV therapy until their T-cell count reaches 350. What? Are they crazy? The answer is no. Gone are the days of seeing your doc, getting a battery of tests done, and walking out with your own personal pharmacy, regardless of your T-cell level.
The implication for the newly infected patient without symptoms of AIDS is clear: it's better to wait before beginning HIV "chemotherapy." However, what about someone who's been on drug for years and is now faced with a decision to divorce themselves from a lengthy marriage to their pharmaceuticals? This split-up also means leaving a "family" that includes two precious offspring -- undetectable viral load and high T-cell count.
Let's look at the facts in this family feud:
So, it's probably time for chronically infected but otherwise healthy folks (and their docs) to re-examine the role that long-term drug therapy plays in their management of HIV disease. The CFA can provide information to help you make these tough decisions about when to start (or stop) therapy. Whether you've been recently diagnosed or are treatment experienced, there are options; most will require some suspension of fear from the past and a leap of faith into the future.
Back to the HIV Treatment ALERTS! November 2001 contents page.